Evidence map›Paper›PMID 25285887›Full record

Trial reportInternational journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience2014

Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.

Landhing M Moran, Sylvia Fitting, Rosemarie M Booze, Katy M Webb, Charles F Mactutus

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Neurocognitive Complications of Pediatric HIV Infections.Current topics in behavioral neurosciences · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2018
    Article
  10. Article
  11. HIV, Tat and dopamine transmission.Neurobiology of disease · 2017
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Landhing M MoranUniversity of South Carolina, Behavioral Neuroscience Program, Department of Psychology, Columbia, SC 29208, USA.
Sylvia FittingUniversity of South Carolina, Behavioral Neuroscience Program, Department of Psychology, Columbia, SC 29208, USA.
Rosemarie M BoozeUniversity of South Carolina, Behavioral Neuroscience Program, Department of Psychology, Columbia, SC 29208, USA.
Katy M WebbUniversity of South Carolina, Behavioral Neuroscience Program, Department of Psychology, Columbia, SC 29208, USA.
Charles F MactutusUniversity of South Carolina, Behavioral Neuroscience Program, Department of Psychology, Columbia, SC 29208, USA. Electronic address: mactutus@mailbox.sc.edu.
University of South Carolina · US

Funding

HIV/COCAINE NEUROTOXICITY IN FEMALESR01DA013137 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BOOZE, ROSEMARIE M, MACTUTUS, CHARLES F. · 2000 to 2021
$7.7M
Maternal HIV: Developmental Neurotoxicity - Administrative SupplementR01HD043680 · NICHD · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BOOZE, ROSEMARIE M, MACTUTUS, CHARLES F. · 2003 to 2016
$2.8M
HIV/Cocaine Neurotoxicity in FemalesK02DA014401 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BOOZE, ROSEMARIE M · 2001 to 2005
$539k
Methamphetamine and HIV-1: NMDAR/D1 mediated neurologic effectsR03DA031604 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI MACTUTUS, CHARLES F. · 2011 to 2012
$290k
NICHD NIH HHS HD043680NICHD NIH HHS R01 HD043680NIDA NIH HHS DA013137NIDA NIH HHS DA014401NIDA NIH HHS DA031604NIDA NIH HHS K02 DA014401NIDA NIH HHS R01 DA013137NIDA NIH HHS R03 DA031604
6 · The paper itself

Abstract

Pediatric AIDS caused by human immunodeficiency virus type 1 (HIV-1) remains one of the leading worldwide causes of childhood morbidity and mortality. HIV-1 proteins, such as Tat and gp120, are believed to play a crucial role in the neurotoxicity of pediatric HIV-1 infection. Detrimental effects on development, behavior, and neuroanatomy follow neonatal exposure to the HIV-1 viral toxins Tat1-72 and gp120. The present study investigated the neurobehavioral effects induced by the HIV-1 neurotoxic protein Tat1-86, which encodes the first and second exons of the Tat protein. In addition, the potential effects of HIV-1 toxic proteins Tat1-86 and gp120 on inflammatory pathways were examined in neonatal brains. Vehicle, 25 μg Tat1-86 or 100 ng gp120 was injected into the hippocampus of male Sprague-Dawley pups on postnatal day 1 (PD1). Tat1-86 induced developmental neurotoxic effects, as witnessed by delays in eye opening, delays in early reflex development and alterations in prepulse inhibition (PPI) and between-session habituation of locomotor activity. Overall, the neurotoxic profile of Tat1-86 appeared more profound in the developing nervous system in vivo relative to that seen with the first exon encoded Tat1-72 (Fitting et al., 2008b), as noted on measures of eye opening, righting reflex, and PPI. Neither the direct PD1 CNS injection of the viral HIV-1 protein variant Tat1-86, nor the HIV-1 envelope protein gp120, at doses sufficient to induce neurotoxicity, necessarily induced significant expression of the inflammatory cytokine IL-1β or inflammatory factors NF-κβ and I-κβ. The findings agree well with clinical observations that indicate delays in developmental milestones of pediatric HIV-1 patients, and suggest that activation of inflammatory pathways is not an obligatory response to viral protein-induced neurotoxicity that is detectable with behavioral assessments. Moreover, the amino acids encoded by the second tat exon may have unique actions on the developing hippocampus.

Indexed as

Age FactorsAmino Acid Transport Systems, NeutralAnimalsAnimals, NewbornCytokinesDevelopmental DisabilitiesDisease Models, AnimalDose-Response Relationship, DrugEmbryo, MammalianFemaleHippocampusHIV Envelope Protein gp120HumansMaleMotor ActivityOrientationAmino Acid Transport Systems, NeutralCytokinesgp120 protein, Human immunodeficiency virus 1HIV Envelope Protein gp120SLC16A10 protein, humanCytokinesDevelopmental delaygp120HIV-1NeurotoxicityTat(1–86)

Identifiers

PMID25285887
PMCPMC4268159
OpenAlexW1967197759

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.